Results 241 to 250 of about 36,545 (280)
Some of the next articles are maybe not open access.

Neuromuscular Blocking Agents

Journal of Pharmacy Practice, 1994
Neuromuscular blocking (NMB) agents are frequently used in the operating room (OR) as well as the intensive care units. The number of NMB agents available for use in these areas continues to increase. The clinician currently has 10 agents from which to choose, with another (rocuronium) soon to be available.
openaire   +1 more source

Isomeric Carborane Neuromuscular Blocking Agents

ChemMedChem, 2019
AbstractWe synthesized a family of neuromuscular blocking agents (NMB) based on decamethonium, but containing a carborane cluster in the methylene chain between the two quaternary ammonium groups. The carborane cluster isomers o‐NMB, m‐NMB, and p‐NMB were tested in animals for neuromuscular block and compared with agents used clinically: rocuronium and
Lalit N. Goswami   +8 more
openaire   +2 more sources

LITHIUM CARBONATE AND NEUROMUSCULAR BLOCKING AGENTS

Survey of Anesthesiology, 1977
The effects of lithium carbonate on the responses to five neuromuscular blocking agents were evaluated in dogs anesthetized with halothane (1 per cent) and N2O (60 per cent) in O2. Latency (time from first twitch-height depression to maximal blockade), maximal twitch-height depression, and times to return to 50 per cent and 100 per cent control twitch ...
G E, Hill, K C, Wong, M R, Hodges
openaire   +2 more sources

Neuromuscular Blocking Agents

1990
In animal experiments succinylcholine increases ICP (Cottrell et al. 1983, Lanier et al. 1986). The increase in ICP is also observed after pre-treatment with thiopentone (Thiagarajah et al. 1988). In dogs subjected to succinylcholine injection, CBF increases within a few minutes and this hyperperfusion is accompanied by EEG activation (Mori et al. 1973,
Jörn Bo Madsen, Georg Emil Cold
openaire   +1 more source

Disadvantages of Neuromuscular Blocking Agents

Veterinary Clinics of North America: Small Animal Practice, 1992
Neuromuscular blocking agents have few indications and significant contraindications or problems associated with their use. The need for controlled ventilation and the difficulties of monitoring anesthetic depth when using neuromuscular blocking agents are overriding factors that mitigate against their routine use.
openaire   +2 more sources

Neuromuscular blocking agents

2023
Manuel Martin Flores, Bhupinder Singh
openaire   +1 more source

Neuromuscular blocking agents

The American Journal of Medicine, 1955
openaire   +2 more sources

Neuromuscular Blocking Agents

Veterinary Clinics of North America: Small Animal Practice, 1992
openaire   +2 more sources

Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study

British Journal of Anaesthesia, 2023
Paul-Michel Mertes   +2 more
exaly  

Home - About - Disclaimer - Privacy